Oruka Therapeutics, Inc. (ORKA)

NGM – Real Time Price. Currency in USD

106.56

+1.88 (1.80%)

Market open: Aug 12, 2026, 1:10 PM EDT

103.00

-1.68 (-1.60%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

11.08.2026

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

PTGX, ALMS, ORKA and VNDA offer diverse psoriasis opportunities, spanning approved therapies, late-stage candidates and earlier-stage programs.

10.08.2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

EVERLAST-A Week 28 data expected at the end of 3Q 2026; 52-week data for all participants expected in December 2026 EVERLAST-B fully enrolled ahead of schedule, with Week 16 data now expected in 4Q 2026 Phase 3 program for ORKA-001 expected to begin in 1H 2027 ORCA-SURGE Week 16 data accelerated, now expected in 1Q 2027 ORCA-SPLASH, a Phase 2 trial of ORKA-002 in moderate-to-severe hidradenitis suppurativa, initiated ORKA-004, a novel half-life extended monoclonal antibody targeting TL1A, to enter the clinic in 4Q 2026 Cash, cash equivalents and marketable securities of $1.1 billion expected to fund the Company through a BLA filing for ORKA-001

Videos

No Data

There is no data to display

Press releases

10.08.2026

Oruka Therapeutics, Inc. (ORKA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Oruka Therapeutics, Inc. (ORKA)

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videos

No Data

Press releases

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videos

No Data

Press releases

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Search stocks

Oruka Therapeutics, Inc. (ORKA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Oruka Therapeutics, Inc. (ORKA)

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videos

No Data

Press releases

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videos

No Data

Press releases

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update